NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1000

Registration Number: NCT00000787

Locations: 🇺🇸
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, United States

A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies

Phase 3

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-09-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00001016

Locations: 🇺🇸
Warner-Lambert Parke-Davis, Morris Plains, New Jersey, United States

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

Completed

Conditions: HIV Infections
Histoplasmosis

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00006316

Locations: 🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States
🇺🇸
Cook County Hosp, Chicago, Illinois, United States

and more 10 locations

A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Completed

Conditions: Cytomegalovirus Infections
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 400

Registration Number: NCT00001089

Locations: 🇺🇸
Louis A Weiss Memorial Hosp, Chicago, Illinois, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis, Indiana, United States

and more 33 locations

Study of Women Who Have AIDS

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1250

Registration Number: NCT00001050

Locations: 🇺🇸
SUNY - Brooklyn, Brooklyn, New York, United States

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT00000892

Locations: 🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Mount Sinai Med Ctr, New York, New York, United States
🇺🇸
Univ of Tennessee / E Tennessee Comprehensive Hemophilia Ctr, Knoxville, Tennessee, United States

and more 42 locations

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 30

Registration Number: NCT00000757

Locations: 🇺🇸
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma

Phase 1

Completed

Conditions: HIV Infections
Sarcoma, Kaposi

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00000694

Locations: 🇺🇸
Mem Sloan - Kettering Cancer Ctr, New York, New York, United States

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 55

Registration Number: NCT00007202

Locations: 🇺🇸
AIDS Research Consortium of Atlanta, Inc. (ARCA) AIEDRP CRS, Atlanta, Georgia, United States
🇺🇸
Feinberg School of Medicine, HIV/ACTU AIEDRP CRS, Chicago, Illinois, United States
🇺🇸
Rush Univ. Med. Ctr., Dept. of Infectious Disease AIEDRP CRS, Chicago, Illinois, United States

and more 2 locations

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

Phase 3

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 2500

Registration Number: NCT00000748

Locations: 🇺🇸
Community Consortium of San Francisco, San Francisco, California, United States
🇺🇸
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
🇺🇸
AIDS Research Alliance - Chicago, Chicago, Illinois, United States

and more 21 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy